Literature DB >> 2567116

DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis.

B S Kerem1, J A Buchanan, P Durie, M L Corey, H Levison, J M Rommens, M Buchwald, L C Tsui.   

Abstract

Patients with cystic fibrosis (CF) generally suffer from chronic obstructive lung disease, pancreatic insufficiency (PI), and a number of other exocrine malfunctions. Approximately 15% of CF patients are, however, pancreatic sufficient. To investigate whether the two clinical subgroups, PI and pancreatic sufficiency (PS), are caused by different CF mutant alleles, we have performed linkage disequilibrium and haplotype association analysis with three DNA markers that are tightly linked to the CF locus. The study showed that the allelic and haplotype distributions for these RFLPs are significantly different between the two groups. The data suggest that most of the CF-PI patients are probably descendants of a single mutational event at the CF locus and that the CF-PS patients resulted from multiple, different mutations. While final interpretation of these data awaits molecular cloning of the CF gene, the information on haplotype association in CF may be useful in genetic counseling and disease prognosis, in identifying the gene itself, and in defining the mutations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567116      PMCID: PMC1715674     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

Review 1.  Reverse genetics and human disease.

Authors:  S H Orkin
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

2.  Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study.

Authors:  A Beaudet; A Bowcock; M Buchwald; L Cavalli-Sforza; M Farrall; M C King; K Klinger; J M Lalouel; G Lathrop; S Naylor
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

3.  Report of the committee on the genetic constitution of chromosomes 7, 8 and 9.

Authors:  M A Spence; L C Tsui
Journal:  Cytogenet Cell Genet       Date:  1987

4.  Nonuniform recombination within the human beta-globin gene cluster.

Authors:  A Chakravarti; K H Buetow; S E Antonarakis; P G Waber; C D Boehm; H H Kazazian
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

5.  Course of cystic fibrosis in black patients.

Authors:  R C Stern; C F Doershuk; T F Boat; A S Tucker; F P Primiano; L W Matthews
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

6.  A closely linked genetic marker for cystic fibrosis.

Authors:  R White; S Woodward; M Leppert; P O'Connell; M Hoff; J Herbst; J M Lalouel; M Dean; G Vande Woude
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

7.  Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency.

Authors:  K J Gaskin; P R Durie; L Lee; R Hill; G G Forstner
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

8.  Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  P R Durie; G G Forstner; K J Gaskin; D J Moore; G J Cleghorn; S S Wong; M L Corey
Journal:  Pediatr Res       Date:  1986-03       Impact factor: 3.756

9.  Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker.

Authors:  L C Tsui; M Buchwald; D Barker; J C Braman; R Knowlton; J W Schumm; H Eiberg; J Mohr; D Kennedy; N Plavsic
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

10.  Localization of cystic fibrosis locus to human chromosome 7cen-q22.

Authors:  B J Wainwright; P J Scambler; J Schmidtke; E A Watson; H Y Law; M Farrall; H J Cooke; H Eiberg; R Williamson
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

View more
  29 in total

1.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

2.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

Authors:  B S Kerem; J Zielenski; D Markiewicz; D Bozon; E Gazit; J Yahav; D Kennedy; J R Riordan; F S Collins; J M Rommens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 3.  Identification of the cystic fibrosis gene.

Authors:  R A Knight; M E Hodson
Journal:  BMJ       Date:  1990-02-10

4.  Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis.

Authors:  S R Miller; R H Schwartz
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

5.  Requirements for ion and solute transport, and pH regulation during enamel maturation.

Authors:  Rodrigo S Lacruz; Charles E Smith; Pierre Moffatt; Eugene H Chang; Timothy G Bromage; Pablo Bringas; Antonio Nanci; Sanjeev K Baniwal; Joseph Zabner; Michael J Welsh; Ira Kurtz; Michael L Paine
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

Review 6.  The cystic fibrosis gene.

Authors:  P J Scambler
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

Review 7.  Why is the cystic fibrosis gene so frequent?

Authors:  G Romeo; M Devoto; L J Galietta
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

8.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

Review 9.  The cystic fibrosis gene: a molecular genetic perspective.

Authors:  Lap-Chee Tsui; Ruslan Dorfman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

10.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.